The present study has been performed to develop a PCR technology to identify human immunoglobulin(Ig) allotypes with restriction fragment length polymorphism(RFLP) using a probe. Genomic DNA were ampilified with PCR tecnology using primers from peripheral blood lymphocytes of 10 periodontal patiens, whose Ig allotypes have been pre-determined by serological tecnique using heagglutination technique. The result indicated that the RFLP patterns could successfully differentiate the Ig allotypes, which suggests that this technology can be developed as a tool useful for population genetics studies.
DNA ; Genetics, Population ; Humans ; Immunoglobulin Allotypes* ; Immunoglobulins* ; Lymphocytes ; Polymerase Chain Reaction* ; Polymorphism, Restriction Fragment Length

The present study was done to evaluate the environmental factors responsible for the expression of Porphyromonas gingivalis heat shock protein. The intensity of the heat shock protein gene expression was comparable to those seen by the heat shock ptreatment of the bacteria (44 degrees C) when the bacteria was grown as a mixed culture or biofilm state at 37degrees C.
Bacteria ; Biofilms ; Gene Expression ; Heat-Shock Proteins* ; Hot Temperature* ; Porphyromonas gingivalis* ; Porphyromonas* ; Shock

No abstract available.
Humans

No abstract available.
Fusobacterium nucleatum* ; Fusobacterium* ; Immunization* ; Porphyromonas gingivalis* ; Porphyromonas*

The aim of the study was to see the total IgG and IgG subclass responses against Aa and Pg in the four early onset periodontitis (EOP) subforms or adult periodontitis (AP). 6 patients consisting of 3 patients from subform I (distinctive LJP pattern), 19 from subform II (post-juvenile periodontitis pattern), 16 from subform III ( LJP pattern but rapidly progressing), 24 from age-matched AP (20-40 years of age) have been selected for the measurements of the total IgG and each IgG subclass against to Pg and the IgG subclass against Aa, respectively. The total IgG titers against to Pg of the subforms I & III had a significantly higher values than subforms II and IV (P<0.05). Among the IgG subclasses, only the lgG3 levels were significantly higher in the subform I than the subform IV(P <0.05). Wide ranges of the antibody titers were noted in all of the EOP subforms and the AP. Except for the subform I, which was typical of localized form, the IgG2 subclass levels to Pg gradually became higher in accordance with the subforms II, III and IV. Both of IgG2 and the IgG4 antibody levels of the EOP were significantly higher than those of AP, while other subclasses were not. All of the four IgG subclass levels to Pg were consistently found to be higher in the younger age group around 20. The levels found to be low around the thirties and then gradually became higher at the ages of late thirties. The IgG2 titer to Aa in the subform I was significantly higher than those of any other subforms. Combinations of IgG1+2+4 were the most frequently found to be elevated followed by the IgG4 only, the IgG2 only, the IgG2+4, the IgG2+3+4, and the IgG1 only, in the descending order.
Aggregatibacter actinomycetemcomitans ; Aggressive Periodontitis* ; Chronic Periodontitis ; Humans ; Immunoglobulin G* ; Periodontitis ; Porphyromonas gingivalis

No abstract available.
Biofilms* ; Porphyromonas gingivalis

No abstract available.
Dental Occlusion ; Dental Restoration, Permanent ; Education, Dental, Continuing ; Dental Care

Periodontal disease, as a polymicrobial disease, is globally endemic as well as being a global epidemic. It is the leading cause for tooth loss in the adult population and has been positively related to life-threatening systemic diseases such as atherosclerosis and diabetes. As a result, it is clear that more sophisticated therapeutic modalities need to be developed, which may include vaccines. Up to now, however, no periodontal vaccine trial has been successful in satisfying all the requirements; to prevent the colonization of a multiple pathogenic biofilm in the subgingival area, to elicit a high level of effector molecules such as immunoglobulin sufficient to opsonize and phagocytose the invading organisms, to suppress the induced alveolar bone loss, or to stimulate helper T-cell polarization that exerts cytokine functions optimal for protection against bacteria and tissue destruction. This article reviews all the vaccine trials so as to construct a more sophisticated strategy which may be relevant in the future. As an innovative strategy to circumvent these barriers, vaccine trials to stimulate antigen-specific T-cells polarized toward helper T-cells with a regulatory phenotype (Tregs, CD4+, CD25+, FoxP3+) have also been introduced. Targeting not only a single pathogen, but polymicrobial organisms, and targeting not only periodontal disease, but also periodontal disease-triggered systemic disease could be a feasible goal.
Adult ; Alveolar Bone Loss ; Atherosclerosis ; Bacteria ; Biofilms ; Colon ; Humans ; Immunization ; Immunoglobulins ; Periodontal Diseases ; Periodontitis ; Phenotype ; T-Lymphocytes ; T-Lymphocytes, Helper-Inducer ; Tooth Loss ; Vaccines

No abstract available.
Biofilms* ; Lymphocytes* ; Porphyromonas gingivalis

No abstract available.
Antibody Formation* ; Heat-Shock Proteins* ; Hot Temperature* ; Humans ; Periodontitis ; Porphyromonas gingivalis* ; Porphyromonas*